In a systematic literature review, researchers from Canada and Japan found that the antipsychotic aripiprazole (Abilify) was significantly and causally related to increased increased psychosis, agitation and aggression. Results appear in this month’s Psychopharmacology.
Abstract (and 1st two pages) →
Takeuchi, H., Remington, G.; A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder. Psychopharmacology. Online June 2013
